Issues and Updates in Emerging Neurologic Viral Infections

ABSTRACT

This review discusses the recent advances in the identification of viral pathogens and other etiologies responsible for cases of suspected viral encephalitis. The authors describe new molecular diagnostic strategies for identifying novel causes of viral encephalitis, including MassTag PCR, DNA microarrays, and high-throughput DNA pyrosequencing. They also highlight the increasing recognition of immune-mediated causes of encephalitis among those cases previously thought to be viral encephalitis of unknown etiology. Lastly, they review some of the most recent updates in the field of emerging neurologic viral infections impacting the United States, including the neurologic complications of H1N1 virus and the reemergence of dengue virus in the Florida Keys.

KEYWORDS

Viral encephalitis - MassTag PCR - DNA microarray - high-throughput DNA pyrosequencing - dengue fever - H1N1 influenza virus - autoimmune encephalitis

REFERENCES

• 1 Tyler K L. Emerging viral infections of the central nervous system: part 1.  Arch Neurol. 2009;  66 (8) 939-948
• 2 Tyler K L. Emerging viral infections of the central nervous system: part 2.  Arch Neurol. 2009;  66 (9) 1065-1074
• 3 Griffin D E. Emergence and re-emergence of viral diseases of the central nervous system.  Prog Neurobiol. 2010;  91 (2) 95-101
• 4 Glaser C A, Gilliam S, Schnurr D California Encephalitis Project, 1998-2000 et al. In search of encephalitis etiologies: diagnostic challenges in the California Encephalitis Project, 1998-2000.  Clin Infect Dis. 2003;  36 (6) 731-742
• 5 Glaser C A, Honarmand S, Anderson L J et al.. Beyond viruses: clinical profiles and etiologies associated with encephalitis.  Clin Infect Dis. 2006;  43 (12) 1565-1577
• 6 Granerod J, Tam C C, Crowcroft N S, Davies N WS, Borchert M, Thomas S L. Challenge of the unknown. A systematic review of acute encephalitis in non-outbreak situations.  Neurology. 2010;  75 (10) 924-932
• 7 Lipkin W I. Microbe hunting in the 21st century.  Proc Natl Acad Sci U S A. 2009;  106 (1) 6-7
• 8 Lipkin W I. Pathogen discovery.  PLoS Pathog. 2008;  4 (4) e1000002
• 9 Briese T, Palacios G, Kokoris M et al.. Diagnostic system for rapid and sensitive differential detection of pathogens.  Emerg Infect Dis. 2005;  11 (2) 310-313
• 10 Lamson D, Renwick N, Kapoor V et al.. MassTag polymerase-chain-reaction detection of respiratory pathogens, including a new rhinovirus genotype, that caused influenza-like illness in New York State during 2004-2005.  J Infect Dis. 2006;  194 (10) 1398-1402
• 11 Palacios G, Briese T, Kapoor V et al.. MassTag polymerase chain reaction for differential diagnosis of viral hemorrhagic fever.  Emerg Infect Dis. 2006;  12 (4) 692-695
• 12 Dominguez S R, Briese T, Palacios G et al.. Multiplex MassTag-PCR for respiratory pathogens in pediatric nasopharyngeal washes negative by conventional diagnostic testing shows a high prevalence of viruses belonging to a newly recognized rhinovirus clade.  J Clin Virol. 2008;  43 (2) 219-222
• 13 Wang D, Coscoy L, Zylberberg M et al.. Microarray-based detection and genotyping of viral pathogens.  Proc Natl Acad Sci U S A. 2002;  99 (24) 15687-15692
• 14 Wang D, Urisman A, Liu Y T et al.. Viral discovery and sequence recovery using DNA microarrays.  PLoS Biol. 2003;  1 (2) E2
• 15 Chiu C Y, Urisman A, Greenhow T L et al.. Utility of DNA microarrays for detection of viruses in acute respiratory tract infections in children.  J Pediatr. 2008;  153 (1) 76-83
• 16 Ksiazek T G, Erdman D, Goldsmith C S SARS Working Group et al. A novel coronavirus associated with severe acute respiratory syndrome.  N Engl J Med. 2003;  348 (20) 1953-1966
• 17 Urisman A, Molinaro R J, Fischer N et al.. Identification of a novel gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant.  PLoS Pathog. 2006;  2 (3) e25
• 18 Chiu C Y, Greninger A L, Kanada K et al.. Identification of cardioviruses related to Theiler's murine encephalomyelitis virus in human infections.  Proc Natl Acad Sci U S A. 2008;  105 (37) 14124-14129
• 19 Kistler A L, Gancz A, Clubb S et al.. Recovery of divergent avian bornaviruses from cases of proventricular dilatation disease: identification of a candidate etiologic agent.  Virol J. 2008;  5 88
• 20 Palacios G, Druce J, Du L et al.. A new arenavirus in a cluster of fatal transplant-associated diseases.  N Engl J Med. 2008;  358 (10) 991-998
• 21 Quan P L, Wagner T A, Briese T et al.. Astrovirus encephalitis in boy with X-linked agammaglobulinemia.  Emerg Infect Dis. 2010;  16 (6) 918-925
• 22 Tunkel A R, Glaser C A, Bloch K C Infectious Diseases Society of America et al. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America.  Clin Infect Dis. 2008;  47 (3) 303-327
• 23 Vincent A, Buckley C, Schott J M et al.. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis.  Brain. 2004;  127 (Pt 3) 701-712
• 24 Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld M R, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis.  Lancet Neurol. 2011;  10 (1) 63-74
• 25 Darnell R B, Posner J B. Paraneoplastic syndromes affecting the nervous system.  Semin Oncol. 2006;  33 (3) 270-298
• 26 Jarius S, Hoffmann L A, Stich O et al.. Relative frequency of VGKC and ‘classical’ paraneoplastic antibodies in patients with limbic encephalitis.  J Neurol. 2008;  255 (7) 1100-1101
• 27 Dalmau J, Gleichman A J, Hughes E G et al.. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.  Lancet Neurol. 2008;  7 (12) 1091-1098
• 28 Prüss H, Dalmau J, Harms L et al.. Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin.  Neurology. 2010;  75 (19) 1735-1739
• 29 Gable M S, Gavali S, Radner A et al.. Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis.  Eur J Clin Microbiol Infect Dis. 2009;  28 (12) 1421-1429
• 30 de Jong M D, Bach V C, Phan T Q et al.. Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma.  N Engl J Med. 2005;  352 (7) 686-691
• 31 Bautista E, Chotpitayasunondh T, Gao Z Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 Influenza et al. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection.  N Engl J Med. 2010;  362 (18) 1708-1719
• 32 Centers for Disease Control and Prevention .CDC Estimates of 2009 H1N1 Influenza Cases, Hospitalizations and Deaths in the United States, April 2009–March 13, 2010. Available at: http://www.flu.gov/individualfamily/about/h1n1/estimates_2009_h1n1.html Accessed August 26, 2011
• 33 Rellosa N, Bloch K C, Shane A L, Debiasi R L. Neurologic manifestations of pediatric novel h1n1 influenza infection.  Pediatr Infect Dis J. 2011;  30 (2) 165-167
• 34 Fugate J E, Lam E M, Rabinstein A A, Wijdicks E FM. Acute hemorrhagic leukoencephalitis and hypoxic brain injury associated with H1N1 influenza.  Arch Neurol. 2010;  67 (6) 756-758
• 35 Denholm J T, Neal A, Yan B et al.. Acute encephalomyelitis syndromes associated with H1N1 09 influenza vaccination.  Neurology. 2010;  75 (24) 2246-2248
• 36 Schonberger L B, Bregman D J, Sullivan-Bolyai J Z et al.. Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976–1977.  Am J Epidemiol. 1979;  110 (2) 105-123
• 37 Centers for Disease Control and Prevention (CDC) . Preliminary results: surveillance for Guillain-Barré syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine—United States, 2009-2010.  MMWR Morb Mortal Wkly Rep. 2010;  59 (21) 657-661
• 38 Vellozzi C, Broder K R, Haber P et al.. Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010.  Vaccine. 2010;  28 (45) 7248-7255
• 39 Gibbons R V, Vaughn D W. Dengue: an escalating problem.  BMJ. 2002;  324 (7353) 1563-1566
• 40 Domingues R B, Kuster G W, Onuki-Castro F L, Souza V A, Levi J E, Pannuti C S. Involvement of the central nervous system in patients with dengue virus infection.  J Neurol Sci. 2008;  267 (1-2) 36-40
• 41 Soares C N, Faria L C, Peralta J M, de Freitas M RG, Puccioni-Sohler M. Dengue infection: neurological manifestations and cerebrospinal fluid (CSF) analysis.  J Neurol Sci. 2006;  249 (1) 19-24
• 42 Kankirawatana P, Chokephaibulkit K, Puthavathana P, Yoksan S, Apintanapong S, Pongthapisit V. Dengue infection presenting with central nervous system manifestation.  J Child Neurol. 2000;  15 (8) 544-547
• 43 Solomon T, Dung N M, Vaughn D W et al.. Neurological manifestations of dengue infection.  Lancet. 2000;  355 (9209) 1053-1059
• 44 Centers for Disease Control and Prevention (CDC) . Locally acquired Dengue—Key West, Florida, 2009-2010.  MMWR Morb Mortal Wkly Rep. 2010;  59 (19) 577-581